Showing of 0 - 10 from 398 results
Pharma - Total results - 398
Jan 12, 2017
Donald Trump's press conference: Russia did it, CNN is fake and other things we learnedDonald Trump shocked everyone with his first press conference as the US president-elect on Wednesday as he threw one bouncer after another
Jan 05, 2017
From R&D boost to tax sops: 5 steps that can prop pharma revenue to $70 bn by 2020Almost 20 percent of global exports in generics from India make it the largest provider of generic medicines globally.
Dec 20, 2016
Sun Pharma arm seeks USFDA nod for voluntary withdrawal of 28 ANDAs of RanbaxyThese older drug products belong to erstwhile Ranbaxy Laboratories and are not being marketed in the US since 2008
Dec 01, 2016
Delhi HC sets aside Centre's ban on 344 fixed dose combination medicinesDefending its stand, the Centre had argued that the FDC medicines are "new drugs" and thus, require licence from Drugs Controller General for sale and manufacture.
Nov 23, 2016
Sun Pharma to acquire Russian co JSC Biosintez for $60 millionThe Indian company will also assume Russian company's debt of $36 million
Nov 22, 2016
Bliss GVS Pharma arm wins $111 mn healthcare services contract from Kenyan firmThis contract covers outpatient services for over 3,04,060 members
Nov 16, 2016
Sun Pharma arm Taro recalls 17,100 kits of dandruff care kits in USThe therapeutic 2-step Kamedis Bio-Herbal Dandruff Care System is used for treating itching and flaking associated with dandruff and seborrheic dermatitis
Nov 08, 2016
Compat overrules CCI's Rs 64 crore fine imposed on GlaxosmithKline, SanofiThe tribunal's order comes more than a year after the CCI had slapped Rs 64 crore fine on the two firms for alleged collusive bidding in supply of a meningitis vaccine to the government for Haj pilgrims
Nov 08, 2016
US election 2016: How the outcome will impact Indian rupee, equities, tradeA resurgence of risk-aversion sentiment globally will impact emerging market currencies in general and expose rupee to potential pressure
Nov 07, 2016
Hillary win may pose pricing challenges for pharma cos: ReportA Democrat sweep in US polls may pose even greater pricing challenges for the pharma industry and pave the way for tighter pricing regulations for both brand name and generic drugs, according to a report.